News
-
-
-
PRESS RELEASE
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Moderna submits application to FDA for review of Spikevax 2025-2026 formula targeting SARS-CoV-2 variant LP.8.1, based on FDA guidance for COVID-19 vaccine update. Learn more about Moderna's innovative mRNA technology -
-
-
PRESS RELEASE
Quadient SA: Availability and consultation of the information relating to the Ordinary Annual and Extraordinary General Meeting to be held on 13 June 2025
Quadient SA announces Ordinary Annual and Extraordinary General Meeting on 13 June 2025. Shareholders to participate physically or via live broadcast. Meeting details available on company website -
PRESS RELEASE
QUADIENT SA: Mise à disposition des documents préparatoires à l’Assemblée Générale Ordinaire Annuelle et Extraordinaire du 13 juin 2025
Mise à disposition des documents préparatoires pour Assemblée Générale Ordinaire et Extraordinaire de Quadient SA le 13 juin 2025. Informations consultables sur leur site internet -
-
-